1. Home
  2. SONN vs UPC Comparison

SONN vs UPC Comparison

Compare SONN & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • UPC
  • Stock Information
  • Founded
  • SONN N/A
  • UPC 1998
  • Country
  • SONN United States
  • UPC China
  • Employees
  • SONN N/A
  • UPC 225
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONN Health Care
  • UPC Health Care
  • Exchange
  • SONN Nasdaq
  • UPC Nasdaq
  • Market Cap
  • SONN 2.5M
  • UPC 2.1M
  • IPO Year
  • SONN N/A
  • UPC 2021
  • Fundamental
  • Price
  • SONN $1.40
  • UPC $0.13
  • Analyst Decision
  • SONN Strong Buy
  • UPC
  • Analyst Count
  • SONN 2
  • UPC 0
  • Target Price
  • SONN $38.00
  • UPC N/A
  • AVG Volume (30 Days)
  • SONN 70.3K
  • UPC 803.8K
  • Earning Date
  • SONN 02-13-2025
  • UPC 01-01-0001
  • Dividend Yield
  • SONN N/A
  • UPC N/A
  • EPS Growth
  • SONN N/A
  • UPC N/A
  • EPS
  • SONN N/A
  • UPC N/A
  • Revenue
  • SONN $1,000,000.00
  • UPC $26,725,919.00
  • Revenue This Year
  • SONN N/A
  • UPC N/A
  • Revenue Next Year
  • SONN N/A
  • UPC N/A
  • P/E Ratio
  • SONN N/A
  • UPC N/A
  • Revenue Growth
  • SONN 674.14
  • UPC N/A
  • 52 Week Low
  • SONN $1.30
  • UPC $0.12
  • 52 Week High
  • SONN $18.72
  • UPC $4.32
  • Technical
  • Relative Strength Index (RSI)
  • SONN 37.25
  • UPC 32.05
  • Support Level
  • SONN $1.30
  • UPC $0.12
  • Resistance Level
  • SONN $1.52
  • UPC $0.15
  • Average True Range (ATR)
  • SONN 0.10
  • UPC 0.03
  • MACD
  • SONN -0.00
  • UPC 0.02
  • Stochastic Oscillator
  • SONN 33.33
  • UPC 11.26

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: